Lactiplantibacillus plantarum dsm20174 attenuates the progression of non-alcoholic fatty liver disease by modulating gut microbiota, improving metabolic risk factors, and attenuating adipose inflammation

HIGHLIGHTS

• who: Josu00e9 I. Riezu-Boj et al. from the Department of Nutrition, Food Sciences, and Physiology, University of Navarra, Pamplona, Spain have published the research work: Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation, in the Journal: Nutrients 2022, 5212 of /2022/
• what: Using a NAFLD mouse model fed a high-fat high-fructose (HFHF) diet for weeks the authors show that L.p DSM20174 supplementation of HFHF mice prevented weight gain improved glucose and lipid homeostasis and reduced . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.